Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hector Tamez Aguilar, M.D.

Profile Picture

Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MAInternship & Residency06/2011Internal Medicine
Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MACardiovascular Fellowship06/2016Cardiovascular medicine
Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MAInterventional Cardiology Fellowship06/2017Interventional Cardiology
Resident as a teacher award
1999 - 2005
Scholarship for Academic Excellence

My research focuses in the role of vitamin D and its analogs to cardiovascular diseases as well as the complex interactions between the heart and the kidney (cardio-renal syndrome).

Our research team has several ongoing project both in the basic and clinical fronts. In the former, we are evaluating novel pathways that have a crucial role in cardiovascular and kidney diseases with the help of genetic tools. In the latter, we are analyzing data from a large international, multi-center, placebo-controlled clinical trial (NCT00497146) and we are currently enrolling patients with chronic kidney disease in both observational (NCT01427374) and interventional trials (NCT00892099).

Web site: thadhanilab.org

Are you a patient?

Hector Tamez Aguilar, M.D., M.P.H. sees patients in the Cardiovascular Institute at the Beth Israel Deaconess Medical Center.

For appointments and more information you can contact my office:
Clinical Phone: (617) 667-880
Fax (Confidential): (617) 632-7820

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). Bonekey Rep. 2014; 3:498. PMID: 24605215.
    Citations: 19     
  2. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013 Nov 21; 369(21):1991-2000. PMID: 24256378.
    Citations: 400     Fields:    Translation:Humans
  3. Kalim S, Tamez H, Wenger J, Ankers E, Trottier CA, Deferio JJ, Berg AH, Karumanchi SA, Thadhani RI. Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease. Clin J Am Soc Nephrol. 2013 Nov; 8(11):1927-34. PMID: 23970130.
    Citations: 16     Fields:    Translation:HumansCells
  4. de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ. Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol. 2013 Nov; 24(11):1863-71. PMID: 23929770.
    Citations: 59     Fields:    Translation:Humans
  5. Bhan I, Tamez H, Thadhani R. Impact of new vitamin D data on future studies and treatment. Curr Opin Nephrol Hypertens. 2013 Jul; 22(4):377-82. PMID: 23666416.
    Citations:    Fields:    Translation:HumansAnimals
  6. Friedman AN, Yu Z, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins B. Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis. Am J Nephrol. 2013; 38(1):12-8. PMID: 23816975.
    Citations: 11     Fields:    Translation:Humans
  7. Tamez H, Andress D, Solomon SD, Thadhani R. Reply to "The role of fibroblast growth factor-23 in left atrial volume". Am Heart J. 2013 May; 165(5):e23. PMID: 23622924.
    Citations:    Fields:    Translation:Humans
  8. Tamez H, Kalim S, Thadhani RI. Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens. 2013 Mar; 22(2):204-9. PMID: 23299053.
    Citations: 28     Fields:    Translation:HumansAnimals
  9. Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA. Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int. 2013 Jun; 83(6):1130-5. PMID: 23389417.
    Citations: 19     Fields:    Translation:Humans
  10. Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA. Low blood levels of long-chain n-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications. Am J Nephrol. 2012; 36(5):451-8. PMID: 23128302.
    Citations: 12     Fields:    Translation:Humans
  11. Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E, Pritchett Y, Chang Y, Agarwal R, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Singh B, Zehnder D, Pachika A, Manning WJ, Shah A, Solomon SD, Thadhani R. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J. 2012 Dec; 164(6):902-9.e2. PMID: 23194491.
    Citations: 41     Fields:    Translation:Humans
  12. Tamez H, Thadhani RI. Vitamin D and hypertension: an update and review. Curr Opin Nephrol Hypertens. 2012 Sep; 21(5):492-9. PMID: 22820371.
    Citations: 21     Fields:    Translation:HumansAnimals
  13. Thadhani R, Tamez H, Solomon SD. Vitamin D Therapy and Cardiac Function in Chronic Kidney Disease-Reply. JAMA. 2012 Jun 06; 307(21):2253. PMID: 24104200.
    Citations: 2     Fields:    
  14. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012 Feb 15; 307(7):674-84. PMID: 22337679.
    Citations: 201     Fields:    Translation:Humans
  15. Khankin EV, Mutter WP, Tamez H, Yuan HT, Karumanchi SA, Thadhani R. Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease. PLoS One. 2010 Feb 16; 5(2):e9246. PMID: 20169072.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  16. Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R. Klotho variants and chronic hemodialysis mortality. J Bone Miner Res. 2009 Nov; 24(11):1847-55. PMID: 19419323.
    Citations: 28     Fields:    Translation:Humans
  17. Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol. 2009 May; 20(5):1140-8. PMID: 19389844.
    Citations: 36     Fields:    Translation:Humans
  18. Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F, Ecker JL, Karumanchi SA, Thadhani R. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009 Apr; 22(4):293-9. PMID: 19340713.
    Citations: 24     Fields:    Translation:Humans
  19. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA, Koeffler HP, Thadhani R. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis. 2009 Feb 15; 48(4):418-24. PMID: 19133797.
    Citations: 58     Fields:    Translation:Humans
  20. Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009 Feb; 20(2):388-96. PMID: 19092121.
    Citations: 122     Fields:    Translation:Humans
  21. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008 Aug 07; 359(6):584-92. PMID: 18687639.
    Citations: 672     Fields:    Translation:Humans
  22. Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem. 2008 Aug; 54(8):1339-48. PMID: 18539645.
    Citations: 14     Fields:    Translation:Humans
  23. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol. 2008 Jul; 19(7):1379-88. PMID: 18400938.
    Citations: 77     Fields:    Translation:Humans
  24. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi SA, Thadhani R, Kang PM. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 2007 Oct 23; 104(43):16810-5. PMID: 17942703.
    Citations: 116     Fields:    Translation:HumansAnimals
  25. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007 Oct; 72(8):1004-13. PMID: 17687259.
    Citations: 263     Fields:    Translation:Humans
  26. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007 Jul; 50(1):137-42. PMID: 17515455.
    Citations: 86     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Tamez Aguilar's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (138)
Co-Authors (22)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.